ArticleCancer research and treatment2025

Validation of 2023 FIGO Stage IA1-IIIC2 Endometrial Carcinoma: A Retrospective Analysis of Two Tertiary Centers in South Korea and Taiwan.

Myeong-Seon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.